ANIX News and Press, Anixa Biosciences Inc. From 05/08/24

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines PR Newswire – Company currently collaborates with Cleveland Clinic on breast cancer and ovarian cancer vaccines – SAN JOSE, Calif. , May 8, 2024 ...

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja PR Newswire Dr. Amit Kumar interviewed in latest episode, 'The Vaccine That Could End Breast Cancer' SAN JOSE, Calif. , May 6, 2024 /PRNewswire/ -- Anixa Bio...

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 PR Newswire SAN JOSE, Calif. , April 30, 2024 /PRNewswire/ -...

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board PR Newswire SAN JOSE, Calif. , April 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stag...

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties PR Newswire SAN JOSE, Calif. , March 14, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a...

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress PR Newswire SAN JOSE, Calif. , March 11, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company f...

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial PR Newswire Dose escalation for fourth patient follows successful completion of first cohort SAN JOSE, Calif. , Feb. 12, 2024 /PRNewswire/ -- Anixa Biosciences, I...

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference PR Newswire Conference Investment Track spotlights promising and emerging biotech and healthcare companies advancing the field of oncology SAN JOSE, Calif. , Jan. 29, 2024 /...

2024-01-23 11:01:26 ET More on Anixa Biosciences Anixa Biosciences: No Longer Crickets On Data Anixa Bio falls after Phase 1 data for breast cancer vaccine Seeking Alpha’s Quant Rating on Anixa Biosciences Historical earnings data for Anixa Biosciences...

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology PR Newswire Broad coverage extended to Japan and related regions SAN JOSE, Calif. , Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or t...